Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Neuroone Medical Technologies (NMTC) Profit After Tax (2016 - 2026)

Neuroone Medical Technologies filings provide 15 years of Profit After Tax readings, the most recent being -$2.1 million for Q1 2026.

  • On a quarterly basis, Profit After Tax rose 8.14% to -$2.1 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$6.6 million, a 0.61% decrease, with the full-year FY2025 number at -$3.6 million, up 70.73% from a year prior.
  • Profit After Tax hit -$2.1 million in Q1 2026 for Neuroone Medical Technologies, down from -$1.4 million in the prior quarter.
  • In the past five years, Profit After Tax ranged from a high of $1.8 million in Q4 2024 to a low of -$3.5 million in Q1 2023.
  • Median Profit After Tax over the past 5 years was -$2.8 million (2022), compared with a mean of -$2.3 million.
  • Biggest five-year swings in Profit After Tax: skyrocketed 153.37% in 2024 and later tumbled 180.54% in 2025.
  • Neuroone Medical Technologies' Profit After Tax stood at -$1.7 million in 2022, then tumbled by 93.04% to -$3.3 million in 2023, then skyrocketed by 153.37% to $1.8 million in 2024, then tumbled by 180.54% to -$1.4 million in 2025, then crashed by 45.05% to -$2.1 million in 2026.
  • The last three reported values for Profit After Tax were -$2.1 million (Q1 2026), -$1.4 million (Q4 2025), and -$1.6 million (Q3 2025) per Business Quant data.